stockrowProgyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) EBITDA
Progyny, Inc.'s EBITDA for fiscal 2025 was $90.2M, up 27.7% from $70.6M in fiscal 2024. Over the twelve months to 30 June 2026 it was $117.9M. Over the past ten years it has ranged from −$9.2M (fiscal 2017) to $90.2M (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. Progyny, Inc. ranks 9th of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $90.2M | 27.74% |
| FY2024 | $70.6M | 9.56% |
| FY2023 | $64.5M | 158.46% |
| FY2022 | $24.9M | (25.86%) |
| FY2021 | $33.6M | 228.08% |
| FY2020 | $10.3M | (13.18%) |
| FY2019 | $11.8M | — |
| FY2018 | −$1.5M | — |
| FY2017 | −$9.2M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $41.6M | 12.92% |
| Mar 2026 | $36.9M | 116.57% |
| Dec 2025 | $17.0M | (23.89%) |
| Sep 2025 | $22.4M | (12.52%) |
| 27 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $9.2B |
| HUM Humana Inc. compare | $3.1B |
| CNC Centene Corporation compare | $2.2B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $333.0M |
| PGNY Progyny, Inc. | $117.9M |
| ALHC Alignment Healthcare, Inc. compare | $76.7M |
| CLOV Clover Health Investments, Corp. compare | $12.7M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement